1. Taiwan, Province of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Distribution
Rossmax International Ltd.

Rossmax International Ltd.

4121.TWO
Rossmax International Ltd.TW flagTaipei Exchange
13.30
TWD
-0.15
- -
1.10BMarket Cap
Rossmax International Ltd.
4121.TWO
(Taipei Exchange)

Recent

price

13.30

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
32.21
30.45
31.74
38.91
45.31
46.13
42.36
42.7
41.94
42.2
49.93
48.01
51.27
44.85
45.22
- -
33.64
Revenue per Share
1.51
0.43
0.35
0.17
-0.04
-0.38
0.27
0.37
0.22
0.35
1.84
1.35
2.01
-0.08
-0.34
- -
-0.26
Basic EPS, GAAP
4.22
-0.36
-1.06
-0.13
-3.13
-0.24
-1.99
-1.87
-0.43
0.54
5.13
2.74
3.53
2.3
2.8
- -
2.35
Free Cash Flow per Basic Share
- -
0.38
- -
0.2
- -
- -
- -
- -
0.3
0.1
0.2
1.16
1.09
1.2
0.57
- -
- -
Dividend per Share
12.34
13.26
13.67
13.57
13.45
13.02
13.28
13.66
13.51
13.65
16
15.14
15.72
14.41
14.08
- -
13.43
Book Value per Share
14.34
13.9
14.28
16.39
17.88
16.79
17.71
18
17.82
17.91
22.31
21.46
22.85
21.73
24.43
- -
23.28
Tangible Book Value per Share
71
74
73
73
74
74
74
74
74
73
74
82
85
85
85
- -
85
Basic Weighted Avg Shares
2,287
2,243
2,328
2,854
3,334
3,406
3,128
3,153
3,097
3,094
3,679
3,948
4,345
3,809
3,851
3,800
2,859
Sales/Revenue/Turnover
5.03
1.49
0.32
-2.52
-2.94
-3.73
-3.91
0.48
-0.25
-0.05
3.99
3.45
5.98
0.07
-1.99
-1.91
-1.69
Operating Margin (%)
59
53
59
66
72
75
64
72
70
218
229
244
284
306
331
342
257
Depreciation Expense
107
31
26
13
-3
-28
20
28
17
26
135
111
170
-7
-29
-30
-22
Net Income, GAAP
14.04
47.39
46.57
56.79
- -
- -
- -
44.87
39.44
35.11
14.73
20.05
20.61
95.79
- -
- -
- -
Effective Tax Rate (%)
4.68
1.4
1.11
0.44
-0.08
-0.81
0.64
0.88
0.54
0.83
3.68
2.82
3.92
-0.17
-0.76
-0.79
-0.77
Profit Margin (%)
527
417
547
662
885
937
770
1,024
977
1,017
1,133
974
993
878
1,116
1,073
1,073
Working Capital
206
72
182
145
313
450
110
307
245
821
708
814
863
990
1,017
997
997
LT Debt
1,089
1,095
1,116
1,361
1,466
1,383
1,337
1,352
1,341
1,331
1,660
1,779
1,944
1,851
2,089
1,984
1,984
Total Equity
6.48
1.26
0.3
-2.09
- -
- -
- -
0.48
-0.26
-0.05
4.99
3.97
6.91
- -
- -
- -
- -
Return on Invested Capital (%)
9.09
2.93
2.28
1.22
- -
- -
- -
2.52
1.59
2.15
5.76
4.36
5.15
-0.44
- -
- -
- -
Return on Capital (%)
13.26
3.4
2.61
1.26
-0.27
-2.84
2.07
2.78
1.65
2.57
12.43
9.19
13.21
-0.52
-2.42
-2.55
-1.88
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jun'25
Sep'25
Dec'25
ST Debt
293
- -
345
LT Borrowings
131
- -
187
LT Finance Leases
878
- -
811
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
84
83
83
Market Capitalization
1,239
1,236
1,326

Working Capital

FRC

•

in mil. unless spec.
Jun'25
Sep'25
Dec'25
Total Current Assets
2,119
- -
2,245
Cash, Cash Equivalents & STI
728
- -
839
Accounts Receivable, Net
239
- -
225
Inventories
1,004
- -
1,022
Total Current Liabilities
1,051
- -
1,172
Payables & Accruals
- -
- -
- -
ST Debt
293
- -
345
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.04%
3.9%
-5.02%
Free Cash Flow
125.65%
-4.17%
-0.75%
Net Income, GAAP
58.02%
54.68%
1.87%
Sales/Revenue/Turnover
1.45%
0.96%
-1.34%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
931
984
934
960
3,809
2024
951
957
974
970
3,851
2025
926
982
- -
951
3,800

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
0.11
-0.02
0.04
- -
-0.08
2024
0.04
-0.09
-0.14
- -
-0.34
2025
-0.12
-0.06
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.2
2024
- -
- -
- -
- -
0.57
2025
- -
- -
- -
- -
- -
Similar Companies
Oriola Oyj (0NES.L)
MedFirst Healthcare Services, Inc. (4175.TWO)
Zynex, Inc. (ZYXIQ)
Ebos Group Limited (EBO.NZ)
Nexus Surgical and Medicare Limited (NEXUSSURGL.BO)
AS ONE Corporation (7476.T)
Business
Rossmax International Ltd. (4121.TWO) develops, manufactures and supplies healthcare products and solutions focused on prevention, monitoring and therapy for chronic conditions including hypertension, diabetes, respiratory diseases, fever management, obesity, wound healing and sleep disorders. The company offers an extensive portfolio encompassing blood pressure monitors featuring PARR Technology for arrhythmia detection, Artery Check Technology pulse oximeters, blood glucose monitoring systems with advanced GDH-FAD technology, non-contact telephoto and infrared ear thermometers with Thermocal calibration, body fat monitors and scales, nebulizers incorporating 3BREATH 3-in-1 respiratory solutions with mesh and valve adjustable technologies, suction units, peak flow meters, sphygmomanometers, stethoscopes, fitness products, hot and pain therapy devices, and the Rossmax healthstyle app for Bluetooth-enabled tracking of blood pressure, glucose, SpO2, weight and temperature; in 2024, it launched the BP5 electric breast pump expanding into kids health solutions. Founded in 1988 and headquartered in Taipei, Taiwan, with a fully integrated production facility in Shanghai, China, Rossmax operates subsidiaries including Rossmax Swiss, Rossmax India and Rossmax Japan, and distributes products across more than 90 countries such as Taiwan, Italy, Brazil, Mainland China, Germany, Ukraine, Poland, Iraq, India, the United Kingdom, Japan, Turkey and others. Recent developments include submission of MDR application in 2025 for enhanced regulatory compliance in Europe, completion of a share buyback program in April 2025 repurchasing 1.45% of shares, introduction of e-commerce and online shop initiatives in 2021-2022 followed by the Rossmax Online Academy in 2023, and ongoing participation in global trade shows like Medica 2025 to showcase innovations.